Tong Ren Tang Technologies' (HKG:1666) attributable profit fell 12% to 521.8 million yuan in 2024 from 590.2 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the traditional Chinese medicine company decreased to 0.41 yuan from 0.46 yuan in the previous year.
Revenue grew 7.2% to 7.26 billion yuan from 6.77 billion yuan a year earlier.
The company declared a final dividend of 0.18 yuan per share, similar to last year's dividend. The dividend will be paid on Aug. 11.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。